site stats

Evofem biosciences investor relations

WebEvofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products and product candidates to address unmet needs in women’s sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Evofem’s sole purpose is to improve ... Web2 days ago · SAN DIEGO, April 12, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced a major new win in New York state that improves coverage for Phexxi® (lactic acid, citric acid ...

Evofem Wins Phexxi Coverage with Largest Payer in New York with …

WebAug 4, 2024 · Evofem continues to expect net product sales in the range of $30 to $35 million for its 2024 fiscal year, representing 264% to 325% growth year-over-year. Gross … WebCurrently, Amy Raskopf holds the position of Head-Investor Relations at Evofem Biosciences, Inc. and Strategic Communications Specialist at In-Site Communications, Inc. Ms. Raskopf previously was ... bridge of scarlet leaves https://olgamillions.com

Evofem Biosciences to Host Investor Call on Thursday, August 11 …

WebJul 28, 2024 · Evofem Biosciences to Report Second Quarter 2024 Results and Provide Corporate Update on Thursday, August 4, 2024 - read this article along with other … WebApr 14, 2024 · SAN DIEGO , April 14, 2024 /PRNewswire/ --Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the appointment of Ivy Zhang as Chief Financial Officer (CFO) and Secretary, effective April 13, 2024.Reporting to Chief Executive Officer Saundra Pelletier, … WebAug 4, 2024 · Amy Raskopf, Evofem Biosciences’ Head of Investor Relations. Ma'am, please go ahead. Amy Raskopf Thank you, and good morning, everyone. Welcome to … bridge of san luis rey

Evofem Wins Phexxi Coverage with Largest Payer in New York …

Category:Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 …

Tags:Evofem biosciences investor relations

Evofem biosciences investor relations

Evofem Biosciences - Funding, Financials, Valuation

Web2 days ago · SAN DIEGO, April 12, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced a major new win in New York state that improves … WebFeb 23, 2024 · PR Newswire. SAN DIEGO, Feb. 23, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM), announced today that its Board of Directors has unanimously approved a comprehensive strategic process ...

Evofem biosciences investor relations

Did you know?

WebEvofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). ... Investor Relations Contact. Amy Raskopf. Evofem ... WebNov 16, 2024 · Evofem Biosciences, Inc. (OTCQB:EVFM) Q3 2024 Results Conference Call November 15, 2024 4:30 PM ETCompany ParticipantsAmy Raskopf - VP, IRSaundra Pelletier - CEOJay File - CFOConference...

WebSep 16, 2024 · Evofem Biosciences, Inc. announced the successful restructuring of its debt, providing forbearance from its debtholders related to all existing events of default. ... The healthcare investor that provided $25 million to Evofem under the April 2024 Securities Purchase and Security Agreement agreed to accept future interest payments as payment … WebApr 11, 2024 · 4 brokerages have issued twelve-month target prices for Evofem Biosciences' stock. Their EVFM share price forecasts range from $3.50 to $8.55. On average, they anticipate the company's stock price to reach $5.35 in the next year. This suggests a possible upside of 24,273.6% from the stock's current price. View analysts …

WebMar 3, 2024 · EVOFEM BIOSCIENCES, INC. : Press releases relating to EVOFEM BIOSCIENCES, INC. Investor relations OTC Markets: EVFM OTC Markets Web2 days ago · — Improves Phexxi coverage for more than 5.8 million New York lives — — Year-to-date, Evofem has gained Phexxi coverage for more than 22.1 million new lives — SAN DIEGO, April 12, 2024 ...

WebAug 11, 2024 · Evofem Biosciences, Inc., (EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, …

WebCurrently, Amy Raskopf holds the position of Head-Investor Relations at Evofem Biosciences, Inc. and Strategic Communications Specialist at In-Site Communications, … can\u0027t remember the name of a gameWeb12400 High Bluff Drive, Suite 600 San Diego, California 92130 1.858.550.1900 can\u0027t remember things anymoreWebMay 4, 2024 · Evofem Biosciences, Inc., (Nasdaq: EVFM) ("Evofem" or the "Company"), today reported financial results for the three-month period ended March 31, 2024. ... bridge of san luis rey abbessWebAug 4, 2024 · Stifel Downgrades Evofem Biosciences to Hold From Buy, Adjusts Price Target to $0.50 Fr.. MT. 2024. HC Wainwright Adjusts Price Target on Evofem … can\u0027t remember the title of a bookWebSupport: 888-992-3836 Home NewsWire Subscriptions ... bridge of scarlet leaves by kristina mcmorrisWebAug 11, 2024 · Evofem Biosciences, Inc., (EVFM) will hold an investor call as follows: Make Yahoo Your Homepage. Discover something new every day from News, Sports, Finance, Entertainment and more! can\u0027t remember thingsWebMay 4, 2024 · Evofem Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Update - read this article along with other careers information, tips … can\u0027t remember to forget